DOJ clears Viatris’ Mylan of generic drug antitrust investigationDOJ does not expect to take any further actions against Viatris in connection with a civil investigative demand related to the pricing and sales of generic drugs. FDA approves Arcutis’ Zoryve for the treatment of atopic dermatitis Adults and children 6 years or older are approved to use the cream. FDA approves 2 Eylea biosimilars Yesafili and Opuviz are interchangeable biosimilars to Regeneron's Eylea. Alembic intros generic Oracea Doxycycline monohydrate is a tetracycline-class drug indicated for the treatment of inflammatory lesions of rosacea in adult patients. Alembic rolls out generic Prolensa Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug indicated for postoperative inflammation in patients who have undergone cataract surgery. NCPA kicks off new TV ad: "PBM Career Day" The new ad is part of NCPA's campaign to push lawmakers to enact pharmacy benefit manager reform. Upsher-Smith receives 2024 ASAP Alliance Excellence Award Upsher-Smith was recognized in the Alliance Program Excellence category. Watch DSN: Walgreens expands role in clinical trials for greater healthcare access DSN senior reporter Sandra Levy visited Perth Amboy, N.J., to discuss the new initiative with the retailer's clinical trials team. Sponsored The 2024 Smarter Purchasing Report: Uncover 5 Key Purchasing Trends Each year, SureCost conducts extensive customer analysis and compiles the anonymized information as a resource for pharmacies. Viatris completes divestitures with closing of OTC business divestiture The completion of the OTC divestiture is a major milestone in the execution of the company's strategic plan. First Previous 31 32 33 34 35 Next Last
